Compare Lemonade Inc (LMND) vs Novartis AG (NVS) Price & Performance

Lemonade IncTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Lemonade Inc vs Novartis AG — how do they compare? Lemonade Inc trades at $52.87 (market cap $4.09B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 72.2× Lemonade Inc's market cap, and Novartis AG pays a 3.07% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals.

	LMND	NVS
Market Cap	$4.09B	$295.37B
Sector	Financials	Health
52-Week High	$96.57	$168.62
52-Week Low	$47.38	$119.31
Enterprise Value	$3.95B	$336.69B
Dividend Yield	—	3.07%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LMND

Lemonade CFO Tim Bixby to present at Oppenheimer tech conference on August 12PRNewsWire · 4 days agoNeutral View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About Lemonade Inc

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.